Post Content
Is KMB a good stock to buy? We came across a bullish thesis on Kimberly-Clark Corporation on Investing Lawyer’s Substack. In this article, we will summarize the bulls’ thesis on KMB. Kimberly-Clark Corporation’s share was trading at $98.25 as of April 27th. KMB’s trailing and forward P/E were 20.22 and 13.11 respectively according to Yahoo Finance.
Nejron Photo/Shutterstock.com
Kimberly-Clark Corporation is a global consumer products leader behind essential everyday brands such as Huggies, Kleenex, and Scott, positioning the company as a resilient operator within the defensive household and personal care segment. The company’s dividend profile remains a central pillar of its investment appeal, with a forward payout ratio of 72.67%, approximately 3.35% dividend growth over the past five years, and an exceptional 52-year track record of consecutive dividend increases, underscoring both consistency and long-term capital return discipline.
Read More: 15 AI Stocks That Are Quietly Making Investors Rich
Read More: Undervalued AI Stock Poised For Massive Gains: 10000% Upside Potential
While the payout ratio suggests moderate headroom rather than aggressive expansion, the strength and stability of Kimberly-Clark’s cash flow generation alleviate concerns around sustainability, supported by the non-discretionary nature of its product portfolio and steady global demand. This resilience becomes particularly valuable in uncertain macroeconomic environments, where consumer staples companies tend to outperform due to inelastic demand characteristics.
Kimberly-Clark’s scale, brand equity, and distribution advantages further reinforce its ability to maintain pricing power and margins, even amid input cost fluctuations. As a result, the company stands out as a compelling recession-resistant investment, offering a combination of dependable income, defensive positioning, and gradual growth.
Even with a relatively modest yield, the durability of earnings and cash flows, alongside disciplined capital allocation, supports a favorable long-term outlook. For investors seeking stability with consistent shareholder returns, Kimberly-Clark represents a high-quality compounder capable of delivering reliable performance across economic cycles while preserving downside protection.
Previously, we covered a bullish thesis on Colgate-Palmolive Company (CL) by Kontra in October 2024, which highlighted the company’s positioning as a quality compounder driven by pricing power, premiumization, and emerging market exposure. CL’s stock price has depreciated by approximately 16.21% since our coverage. Investing Lawyer shares a similar view but emphasizes dividend durability, cash flow stability, and recession-resistant demand.